![Mark Casey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Casey
Conseiller Juridique Général chez
NOVAVAX, INC.
Fortune : 988 035 $ au 31/05/2026
Profil
Mark Joseph Casey is currently Secretary, Chief Legal Officer & Executive VP at Novavax, Inc. since 2023.
Former roles include Secretary & Chief Legal Officer at Bryn Pharma LLC in 2023; Chief Legal Officer & Executive Vice President at Keenova Therapeutics PLC from 2018 to 2022; Secretary, Senior Vice President & General Counsel at Idera Pharmaceuticals, Inc. from 2015 to 2018; Secretary, Chief Administrative Officer & SVP at Hologic, Inc. from 2012 to 2014; Chief Legal Officer & Executive Vice President at Mallinckrodt Pharmaceuticals Ltd.; Chief Patent Counsel, VP & Deputy General Counsel at Cytyc Corp.
from 2002 to 2007; Attorney at Boston Scientific Corp.
from 1998 to 2002; Attorney at EMC Corp.
from 1996 to 1998; Attorney at Digital Equipment Corp.
from 1992 to 1996; Director at MKG Medical UK Ltd. from 2020 to 2025; Director at AdvaMedDx; Director at Third Wave Technologies, Inc. in 2008.
Education includes undergraduate studies at Syracuse University and graduate studies at Suffolk University Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVAVAX, INC. 0,05 % | 23/04/2026 | 90 067 ( 0,05 % ) | 988 035 $ | 31/05/2026 |
Postes actifs de Mark Casey
| Sociétés | Poste | Début |
|---|---|---|
| NOVAVAX, INC. | Conseiller Juridique Général | 11/12/2023 |
Anciens postes connus de Mark Casey
| Sociétés | Poste | Fin |
|---|---|---|
MKG Medical UK Ltd.
 MKG Medical UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 15/01/2025 |
Bryn Pharma LLC
 Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Conseiller Juridique Général | 01/11/2023 |
| MALLINCKRODT PLC | Conseiller Juridique Général | 15/09/2022 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Conseiller Juridique Général | 31/01/2018 |
| HOLOGIC, INC. | Directeur Administratif | 19/12/2014 |
Formation de Mark Casey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Digital Equipment Corp.
 Digital Equipment Corp. Computer Processing HardwareElectronic Technology Makes personal computers and servers | Electronic Technology |
EMC Corp.
 EMC Corp. Computer PeripheralsElectronic Technology Manufactures and sells computer storage devices and provides IT services | Electronic Technology |
Hologic, Inc.
 Hologic, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and supplies diagnostics devices, medical imaging systems & surgical products for women's | Health Technology |
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Cytyc Corp.
 Cytyc Corp. Medical SpecialtiesHealth Technology Manufactures and markets medical diagnostic applications | Health Technology |
Third Wave Technologies, Inc.
 Third Wave Technologies, Inc. BiotechnologyHealth Technology Develops DNA and RNA detection technology | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AdvaMedDx
 AdvaMedDx Miscellaneous Commercial ServicesCommercial Services Operates as a trade association representing diagnostics manufacturers | Commercial Services |
Suffolk University Law School
 Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MKG Medical UK Ltd.
MKG Medical UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
